Global In Silico Clinical Trials Market by Therapeutic Area (Infectious Diseases, Oncology), Phase (Phase I, Phase II, Phase III), Industry - Forecast 2024-2030- Product Image

Sale

Global In Silico Clinical Trials Market by Therapeutic Area (Infectious Diseases, Oncology), Phase (Phase I, Phase II, Phase III), Industry - Forecast 2024-2030

Report
191 Pages
March 2024
Region: Global
360iResearch™
ID: 5716008

UP TO €841EUR$875USD£719GBP OFF until Dec 31^st 2024

The In Silico Clinical Trials Market size was estimated at USD 3.01 billion in 2023, USD 3.19 billion in 2024, and is expected to grow at a CAGR of 7.01% to reach USD 4.85 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the In Silico Clinical Trials Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the In Silico Clinical Trials Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the In Silico Clinical Trials Market, highlighting leading vendors and their innovative profiles. These include Aganitha AI Inc., GNS Healthcare, Insilico Medicine, InSilicoTrials Technologies, Instem Group of Companies, Labcorp Drug Development, Novadiscovery SAS, Thornton Tomasetti, and ZMT Zurich MedTech AG.

Market Segmentation & Coverage

This research report categorizes the In Silico Clinical Trials Market to forecast the revenues and analyze trends in each of the following sub-markets:

Therapeutic Area
- Infectious Diseases
- Oncology
Phase
- Phase I
- Phase II
- Phase III
Industry
- Medical Devices
- Pharmaceutical

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the In Silico Clinical Trials Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the In Silico Clinical Trials Market?
What are the technology trends and regulatory frameworks in the In Silico Clinical Trials Market?
What is the market share of the leading vendors in the In Silico Clinical Trials Market?
Which modes and strategic moves are suitable for entering the In Silico Clinical Trials Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. In Silico Clinical Trials Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of chronic diseases worldwide and need for efficient drugs
5.1.1.2. Growing need for better understanding of the safety and efficacy of a drug or a device
5.1.1.3. Significant rise in R&D expenditure for drug development
5.1.2. Restraints
5.1.2.1. Low awareness about in silico trials in the developing economies
5.1.3. Opportunities
5.1.3.1. Technological advancements in in silico clinical trials
5.1.3.2. Utilization of use advanced computational modeling and simulation tools
5.1.4. Challenges
5.1.4.1. Issues related to protein flexibility, molecule conformation, and promiscuity
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. In Silico Clinical Trials Market, by Therapeutic Area

6.1. Introduction
6.2. Infectious Diseases
6.3. Oncology

7. In Silico Clinical Trials Market, by Phase

7.1. Introduction
7.2. Phase I
7.3. Phase II
7.4. Phase III

8. In Silico Clinical Trials Market, by Industry

8.1. Introduction
8.2. Medical Devices
8.3. Pharmaceutical

9. Americas In Silico Clinical Trials Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific In Silico Clinical Trials Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa In Silico Clinical Trials Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. Aganitha AI Inc.
13.1.2. GNS Healthcare
13.1.3. Insilico Medicine
13.1.4. InSilicoTrials Technologies
13.1.5. Instem Group of Companies
13.1.6. Labcorp Drug Development
13.1.7. Novadiscovery SAS
13.1.8. Thornton Tomasetti
13.1.9. ZMT Zurich MedTech AG
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. IN SILICO CLINICAL TRIALS MARKET RESEARCH PROCESS
FIGURE 2. IN SILICO CLINICAL TRIALS MARKET SIZE, 2023 VS 2030
FIGURE 3. IN SILICO CLINICAL TRIALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. IN SILICO CLINICAL TRIALS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. IN SILICO CLINICAL TRIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. IN SILICO CLINICAL TRIALS MARKET DYNAMICS
FIGURE 7. IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
FIGURE 8. IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
FIGURE 10. IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2023 VS 2030 (%)
FIGURE 12. IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. IN SILICO CLINICAL TRIALS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. IN SILICO CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. IN SILICO CLINICAL TRIALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. IN SILICO CLINICAL TRIALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 6. IN SILICO CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. IN SILICO CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 9. IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 13. IN SILICO CLINICAL TRIALS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 20. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 22. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 23. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 25. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 26. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 27. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 28. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 29. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 30. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 35. ASIA-PACIFIC IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 36. ASIA-PACIFIC IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. AUSTRALIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 40. AUSTRALIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 42. CHINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 43. CHINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 44. CHINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 45. INDIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 46. INDIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 47. INDIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 48. INDONESIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 49. INDONESIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 51. JAPAN IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 52. JAPAN IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 53. JAPAN IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 54. MALAYSIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 55. MALAYSIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 57. PHILIPPINES IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 58. PHILIPPINES IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 60. SINGAPORE IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 61. SINGAPORE IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 63. SOUTH KOREA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 64. SOUTH KOREA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 66. TAIWAN IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 67. TAIWAN IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 69. THAILAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 70. THAILAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 71. THAILAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 72. VIETNAM IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 73. VIETNAM IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 79. DENMARK IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 80. DENMARK IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 81. DENMARK IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 82. EGYPT IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 83. EGYPT IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 84. EGYPT IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 85. FINLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 86. FINLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 87. FINLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 88. FRANCE IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 89. FRANCE IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 90. FRANCE IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 91. GERMANY IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 92. GERMANY IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 93. GERMANY IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 94. ISRAEL IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 95. ISRAEL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 97. ITALY IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 98. ITALY IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 99. ITALY IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 100. NETHERLANDS IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 101. NETHERLANDS IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 103. NIGERIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 104. NIGERIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 106. NORWAY IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 107. NORWAY IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 108. NORWAY IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 109. POLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 110. POLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 111. POLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 112. QATAR IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 113. QATAR IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 114. QATAR IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 121. SOUTH AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 124. SPAIN IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 125. SPAIN IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 126. SPAIN IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 127. SWEDEN IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 130. SWITZERLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 131. SWITZERLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 133. TURKEY IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 134. TURKEY IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 135. TURKEY IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
TABLE 142. IN SILICO CLINICAL TRIALS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 143. IN SILICO CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 144. IN SILICO CLINICAL TRIALS MARKET LICENSE & PRICING

Companies Mentioned

Aganitha AI Inc.
GNS Healthcare
Insilico Medicine
InSilicoTrials Technologies
Instem Group of Companies
Labcorp Drug Development
Novadiscovery SAS
Thornton Tomasetti
ZMT Zurich MedTech AG

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	191
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 3.19 Billion
Forecasted Market Value ( USD ) by 2030	$ 4.85 Billion
Compound Annual Growth Rate	7.0%
Regions Covered	Global
No. of Companies Mentioned	9

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3242EUR$3,374USD£2,772GBP €3602EUR$3,749USD£3,080GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4107EUR$4,274USD£3,511GBP €4563EUR$4,749USD£3,901GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4971EUR$5,174USD£4,250GBP €5524EUR$5,749USD£4,723GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5836EUR$6,074USD£4,990GBP €6485EUR$6,749USD£5,544GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7566EUR$7,874USD£6,468GBP €8406EUR$8,749USD£7,187GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

in Silico Clinical Trials Global Market Report 2024

In Silico Clinical Trials Market Report 2023-2033

Global In Silico Clinical Trials - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Global In Silico Clinical Trials Market Report and Forecast 2023-2031

2024 Global Forecast for In-Silico Clinical Trials Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

About the In Silico Clinical Trials Market